CORRELATION OF CIRCULATING EPSTEIN‐BARR VIRUS‐TARGETED CYTOTOXIC T LYMPHOCYTE PRECURSORS (EBV‐CTLp) AND CLINICAL RESPONSE FOLLOWING TABELECLEUCEL (TAB‐CEL) INFUSION IN PATIENTS WITH EBV‐DRIVEN DISEASE. (12th June 2019)